• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 7, Issue 9
  3. Authors

Online ISSN: 2515-8260

Volume7, Issue9

A PHARMACOLOGICAL COMPARISON BETWEEN the PROBIOTIC PREPARED by the LACTOBACILLUS ACIDOPHILUS BACTERIA and NITAZOXANID in ANIMALS INFECTED WITH CRYPTOSPORIDIOSIS

    Maysoon Mustapha Jasim Rsha shamil Hussin Mohammed Ahmed Mustafa

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 9, Pages 143-156

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

The study was conducted for the period from April 2016 to March 2017. The study of lactobacilli, which was prescribed by acidophillus Lactobacilli (Probiotics), was included in the treatment of the parasite Cryptosporidium parvam compared to nitazoxanid, based on several criteria including therapeutic efficacy and some blood criteria. The number of egg cyst in the first day of the treatment reached 6640 syst / eggs with a therapeutic efficiency of 22.9%. In the first and second concentrations, the ratio reached 7180, 6460 and 5560 with a therapeutic efficiency of 16.7,25.0 and 35. The number of egg cyst continued to decline to the fifth day. The number of eggs cyst was 40 cysts / eggs and 99.4% The number of red blood cells in total infection compared to control was 5.782 × 109 / L, while there was no significant difference in control. The results showed no significant differences in hemoglobin ratios and the volume of red blood cells between total negative control, total probiotic treatment group, and groups treated with drugs in concentrations II and III, and in the number of white blood cells, granulocyte and monocyte were no differences Between the probiotic group and the negative control group, while all the remaining groups decreased
Keywords:
    Cryptosporidium parvam bioenergy. Probiotic
  • PDF (246 K)
  • XML
(2020). A PHARMACOLOGICAL COMPARISON BETWEEN the PROBIOTIC PREPARED by the LACTOBACILLUS ACIDOPHILUS BACTERIA and NITAZOXANID in ANIMALS INFECTED WITH CRYPTOSPORIDIOSIS. European Journal of Molecular & Clinical Medicine, 7(9), 143-156.
Maysoon Mustapha Jasim; Rsha shamil Hussin; Mohammed Ahmed Mustafa. "A PHARMACOLOGICAL COMPARISON BETWEEN the PROBIOTIC PREPARED by the LACTOBACILLUS ACIDOPHILUS BACTERIA and NITAZOXANID in ANIMALS INFECTED WITH CRYPTOSPORIDIOSIS". European Journal of Molecular & Clinical Medicine, 7, 9, 2020, 143-156.
(2020). 'A PHARMACOLOGICAL COMPARISON BETWEEN the PROBIOTIC PREPARED by the LACTOBACILLUS ACIDOPHILUS BACTERIA and NITAZOXANID in ANIMALS INFECTED WITH CRYPTOSPORIDIOSIS', European Journal of Molecular & Clinical Medicine, 7(9), pp. 143-156.
A PHARMACOLOGICAL COMPARISON BETWEEN the PROBIOTIC PREPARED by the LACTOBACILLUS ACIDOPHILUS BACTERIA and NITAZOXANID in ANIMALS INFECTED WITH CRYPTOSPORIDIOSIS. European Journal of Molecular & Clinical Medicine, 2020; 7(9): 143-156.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 166
  • PDF Download: 236
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus